Fusion Pharma

is a Canada-based biopharmaceutical company that researches and develops radiation therapies for the treatment of cancer...
Read more
Fusion Pharma CEO: John Valliant

CEO

John Valliant

CEO Approval Rating

90/100

2014

PublicAcquired by AstraZeneca UK LimitedNASDAQFUSN

2834 NAICS listing
Annual Revenue
$2.1M
Employees
113
Funding
$363.5M
Investments
1

Fusion Pharma Competitors

1SpaceOAR
2Athenex
3ARMO BioSciences
4NGM Bio
5vTv Therapeutics
6Lixte
7POINT
8Alpha-9
9Abdera Therapeutics
10Artbio
See 14+ competitors

Trending Companies